Discovery points toward treatment options beyond insulin injections

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines